NeuroVive Pharmaceutical AB EV/EBITDA
Что обозначает EV/EBITDA в NeuroVive Pharmaceutical AB?
EV/EBITDA NeuroVive Pharmaceutical AB является N/A
Какое определение для EV/EBITDA?
EV / EBITDA - это стоимость предприятия, деленная на прибыль до вычета процентов, налогов, обесценивания и амортизации. При помощи неё измеряется, насколько дорогой является акция, и она более действительна для сравнения компаний, чем для соотношения цены и прибыли. Она измеряет цену (в форме стоимости предприятия), которую инвестор платит в пользу денежного потока компании (в форме EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA компаний в Health Care сектор на OTC по сравнению с NeuroVive Pharmaceutical AB
Что делает NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Компании с ev/ebitda похож на NeuroVive Pharmaceutical AB
- Long Blockchain имеет EV/EBITDA из N/A
- Long Blockchain имеет EV/EBITDA из N/A
- Allot Ltd имеет EV/EBITDA из N/A
- Seneca Biopharma Inc имеет EV/EBITDA из N/A
- Cantex Mine Development имеет EV/EBITDA из N/A
- Rockwealth Resources имеет EV/EBITDA из N/A
- NeuroVive Pharmaceutical AB имеет EV/EBITDA из N/A
- SandRidge Permian Trust имеет EV/EBITDA из N/A
- NetMed имеет EV/EBITDA из N/A
- Tongda Hong Tai имеет EV/EBITDA из N/A
- Aspire Mining имеет EV/EBITDA из N/A
- Linius Technologies имеет EV/EBITDA из N/A
- Cloud DX имеет EV/EBITDA из N/A